Calumet (CLMT) H.C. Wainwright Renewables Fuels Virtual Day presentation summary
Event summary combining transcript, slides, and related documents.
H.C. Wainwright Renewables Fuels Virtual Day presentation summary
25 Mar, 2026Key investment highlights
Two distinct, cash-generating platforms: Specialties and Renewables, both with competitive advantages.
Specialties business has shown robust performance and resilience through market cycles.
Montana Renewables delivers positive Adjusted EBITDA and is expanding SAF production, with much of the new capacity pre-sold at a premium.
Accelerated deleveraging with $220 million debt reduction in 2025 and $80 million annual debt service savings after a federal loan.
Specialties business performance
Historical mid-cycle Adjusted EBITDA averages $286 million, with recent years outperforming this average.
Achieved record production levels and $100 million in cost reductions, including $61 million in opex savings.
Specialty margins remain strong, outpacing historic levels despite a softer macro environment.
Diversified customer base and agile supply chain support margin resilience.
Montana Renewables growth and outlook
Renewable fuels production at 12,000 bpd, increasing to 13,000 bpd in Q2 2026.
SAF production expanding from 30 million to 120–150 million gallons per year with MaxSAF® 150 project.
Over 100 million gallons of SAF pre-sold at a $1–2/gallon premium to renewable diesel.
Facility benefits from geographic advantages, low-cost feedstock access, and short supply chains.
Latest events from Calumet
- Board refreshed, financials strong, and all proposals approved as growth initiatives advance.CLMT
AGM 20262 Jun 2026 - 2025 saw strong revenue, debt reduction, and major renewables growth; board urges support for all proposals.CLMT
Proxy filing18 May 2026 - Strong 2024 results, C-Corp conversion, and major SAF expansion drive governance and compensation focus.CLMT
Proxy filing18 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.CLMT
Proxy filing18 May 2026 - Q3 2025 net income surged to $313.4M, with record EBITDA and SAF expansion progress.CLMT
Q3 202518 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.CLMT
Proxy filing18 May 2026 - Q1 2026 Adjusted EBITDA with Tax Attributes was $50.1M; expansion and supply deals support growth.CLMT
Q1 202618 May 2026 - Adjusted EBITDA up 30% to $293.3M, $222M debt cut, and record specialty output achieved.CLMT
Q4 20257 Apr 2026 - Q2 2024 delivered $66.8M EBITDA, record volumes, and C-Corp conversion amid margin pressure.CLMT
Q2 20241 Feb 2026